Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page history now includes a new revision entry for v3.7.0 and removes the previous v3.6.6 entry, signaling an updated version of the page's metadata in the study record history.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous entry v3.6.5 was removed. This updates the page's version history to reflect the latest revision.SummaryDifference0.1%

- Check62 days agoChange DetectedNothing to report: no additions or deletions were defined.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the history and the previous Revision: v3.6.4 was removed. This reflects a version update in the record-keeping without changing the study information or public page functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history section now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small system update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.